The SIIA is delighted to introduce one of the newest members to join SIIA’s Software & Services Division, Carevoyance. I had a chance to sit down with Anatoly Geyfman, CEO of Carevoyance, to learn a little more about their data driven applications and solutions for the healthcare industry. Please find my interview below.
Rhianna: Tell us a little about Carevoyance and what makes you unique.
Anatoly: Carevoyance is an always-accurate provider directory of every physician in the US, to which we’re linking billions of previously unmapped signals to create the world’s only living economic atlas of healthcare.
Carevoyance is the only place for healthcare market research, competitor insights and actionable data to aid in sales of medical devices, building risk-bearing provider networks and provider utilization analysis.
We are building a platform for comprehensive understanding of our healthcare system.
Rhianna: How important is ‘Customer Success First’ to your business?
Anatoly: Crucial. As with any data-heavy application our job just starts at the end of the sale. Training, ensuring customers receive the best experience and integrating customer feedback into our product development cycle is just the tip of the iceberg. We have regular meetings with our current customers and prospects to check in to see how Carevoyance is doing, show what we’re working on and ask for feedback on current offering.
Rhianna: How can a data-driven approach help healthcare companies increase revenue and gain a competitive edge?
Anatoly: By focusing your sales force on a specific set of providers that match your ideal customer profile, you can both increase the percentage of deals closed per rep, as well as expedite the sales process. Carevoyance lets companies create a buyer profile with relative ease — we link your customer data to our system and do analysis on each of your customer against our repository of buying signals to understand what makes some people buy your product and others not. Then we give you recommendations on which providers to approach based on their revenue potential. Data-driven sales.
Rhianna: How do you see technology changing healthcare in the next 18-24 months?
Anatoly: Value-based care, while nascent today, will be a huge part of the landscape by 2018. CMS projects up to 50% of FFS payments being value-based, not just value-linked. Without a data-driven approach to both sales and network building, organizations will fall behind other who utilize big-data analytics on their provider data.